Comparative characteristics of specific autoantibodies in rheumatoid arthritis

Terapevticheskii Arkhiv

Volumn 77, Issue 12, 2005, Pages 53-59

  Lapin, S V ^a   Maslyansky, A L ^a   Mazurov, V I ^a   Totolyan, A A ^a  

^a NONE

Author keywords

Antibodies to CCP; Antifilaggrine antibodies; Autoantibodies; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIPERINUCLEAR FACTOR; AUTOANTIBODY; BIOLOGICAL MARKER; FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN; KERATIN; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 33144479875     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Waaler E. On the occurrence of a factor in human serum activation the specific agglutination of sheep blood corpuscles. Acta Pathol. Microbiol. Scand. 1940; 17: 172-178.
2. Rose H. M., Ragan C., Pearce E., Lipman M. O. Differential agglutination of normal and sensitized sheep erythrocytes be sera of patients with rheumatoid arthritis. Proc. Soc. Exp. Biol. (N. Y.) 1949; 68: 1-11.
3. Arnett F. C., Edworth S. M., Bloch D. A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr. and Rheum. 1988; 31: 315-324.
4. Nienhuis R. L. F., Mandema E. A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann. Rheum. Dis. 1964; 23: 302-305.
5. Coons A. H., Kaplan M. H. Localization of antigen in tissue cells II: Improvements in the method for the detection of Antigen be means of fluorescent antibody. J. Exp. Med. 1950; 90: 1-13.
6. Young B. J. J., Mallya R. K., Leslie R. D. G. et al. Anti-keratin antibodies in rheumatoid arthritis. Br. Med. J. 1979; 2: 97-99.
7. Simon M., Girbal E., Sebbag M. et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies", autoantibodies specific for rheumatoid arthritis. J. Clin. Invest. 1993; 92: 1387-1393.
8. Sebbag M., Simon M., Vincent C. et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1995; 95: 2672-2679.
9. Girbal E., Sebbag M., Gomes-Daudrix V. et al. Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis. Ann. Rheum. Dis. 1993; 52: 749-757.
10. Girbal E., Durieux J. J., Arnaud M. et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 1999; 162: 585-594.
11. Masson-Bessiere C., Sebbag M., Girbal-Neuhauser E. et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha-and beta-chains of fibrin. J. Immunol. 2001; 166: 4177-4184.
12. Schellekens G. A., de Jong B. A. W., van den Hoogen F. H. J. et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis - specific autoantibodies. J. Clin. Invest. 1998; 101: 273-281.
13. Pincus T. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthr. and Rheum. 1999; 42: 2220-2230.
14. Henderson C. Aminoalkylsilane: An inexpensive simple preparation for slide adhesion. J. Histopathol. 1989; 12: 123-124.